Finance

Beta
Lists
SLS:NASDAQ
Sellas Life Sciences Group Inc
$13.39
+6.10%
(+0.77) 1D
$13.36
-0.22% (-0.030)
After hours
Closed: Jul 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLS...
Open
$12.66
High
$13.64
Low
$12.62
Mkt. cap
2.63B
Avg. vol.
10.59M
Volume
6.07M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.23
Beta
2.42
Shares outstanding
186.03M
No. of employees
13
Open
$12.66
High
$13.64
Low
$12.62
Mkt. cap
2.63B
Avg. vol.
10.59M
Volume
6.07M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.23
Beta
2.42
Shares outstanding
186.03M
No. of employees
13
News stories
From sources across the web
About Sellas Life Sciences Group Inc
CEOAngelos M. Stergiou
Employees13
Founded2006
Headquarters-
SectorBiotechnology
Websitesellaslifesciences.com
Analyst ratings
Based on 2 analysts giving stock ratings to SLS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for SLS in the last 3 months.
Highest
Current $13.39
$30.00 (+124.05%)
Average
$27.50 (+105.38%)
Lowest
$25.00 (+86.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Reiterated
$30.00
+124%
07/08/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
$25.00
+86.7%
07/06/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$25.00
+86.7%
07/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.87M
4.22M
4.73M
5.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.00M
2.87M
2.42M
4.12M
Operating expense
6.87M
7.08M
7.16M
9.25M
Total operating expenses
6.87M
7.08M
7.16M
9.25M
Operating income
-6.87M
-7.08M
-7.16M
-9.25M
Other non operating income
-
-
-
-
EBT including unusual items
-6.60M
-6.79M
-7.66M
-8.41M
EBT excluding unusual items
-6.60M
-6.79M
-6.56M
-8.41M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.60M
-6.79M
-7.66M
-8.41M
Net profit margin
-
-
-
-
Earnings per share
-0.07
-0.06
-0.05
-0.05
Interest and investment income
272.00K
292.00K
597.00K
845.00K
Interest expense
-
-
-
-
Net interest expenses
272.00K
292.00K
597.00K
845.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer